Skip to main content
Clinical Trials/NCT04278482
NCT04278482
Completed
Not Applicable

"Diseño y Validación en Humanos de un Nuevo Complemento Alimenticio Rico en Ácido Docosahexaenoico (DHA) Procedente de Algas"

National Research Council, Spain1 site in 1 country102 target enrollmentStarted: March 10, 2020Last updated:
ConditionsVegetarian Diet

Overview

Phase
Not Applicable
Status
Completed
Sponsor
National Research Council, Spain
Enrollment
102
Locations
1
Primary Endpoint
Serum DHA

Overview

Brief Summary

Vegetarian diets are increasing worldwide. To prevent nutritional deficiencies, supplementation with nutrients that are only present in animal food can be needed. In relation to fatty acids, vegetarian diets involve low intake of omega-3 polyunsaturated fatty acids (n-3 PUFA) and low blood levels of the long-chain n-3 derivatives, whose main dietary sources are fish and shellfish, particularly the levels of docosahexaenoic acid (DHA), which has important health benefits, are low.

In this regard, validation of supplements rich in the n-3 fatty acid DHA that are not obtained from fish is needed, thus the study will test the bioavailability and metabolic effects of a DHA supplement form algae.

The study will be conducted on the effects of the DHA supplement versus placebo in vegetarian and non-vegetarian healthy adults.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adult (age ≥18 and ≤45 years).
  • Participant following either a vegetarian diet during at least 6 months or following a omnivorous diet but consuming fish 2 times per week or less.

Exclusion Criteria

  • Age \<18 and \>45 years old.
  • Pregnancy.
  • Diseases: liver diseases, gastric diseases, irritable bowel, hypercholesterolemia, hypertension, diabetes, biliary colic.
  • Having participated in a clinical study in the last 3 months.
  • Eating disorders.
  • Consumption of foods fortified with omega-3 fatty acids in the last 3 months.
  • Consumption of supplements of omega-3 fatty acids in the last 3 months.
  • Participant who have followed either a vegetarian diet for less than six months or an omnivorous diet including fish more than 2 times per week.

Outcomes

Primary Outcomes

Serum DHA

Time Frame: week 18

Docosahexanoic acid concentration in serum

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
National Research Council, Spain
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

M Pilar Vaquero

Dr

National Research Council, Spain

Study Sites (1)

Loading locations...

Similar Trials